{"id":4274,"date":"2023-05-24T13:42:52","date_gmt":"2023-05-24T05:42:52","guid":{"rendered":"https:\/\/regask.com\/?p=4274"},"modified":"2024-10-17T00:16:15","modified_gmt":"2024-10-16T16:16:15","slug":"webinar-der-fda-zu-dezentralisierten-klinischen-studien","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/fda-decentralized-clinical-trials-webinar\/","title":{"rendered":"US-amerikanische FDA k\u00fcndigt Webinar zur Diskussion dezentraler Studien an\u2026"},"content":{"rendered":"<div>\n<div><a href=\"https:\/\/www.fda.gov\/\" target=\"_blank\" rel=\"noopener\">US-amerikanische FDA<\/a> Die FDA hat k\u00fcrzlich den Leitlinienentwurf f\u00fcr dezentrale klinische Studien ver\u00f6ffentlicht und ein Webinar zu diesem Entwurf anberaumt. Der Leitfadenentwurf befasst sich mit der Frage \u201eDezentrale klinische Studien f\u00fcr Arzneimittel, biologische Produkte und Medizinprodukte \u2013 Leitfaden f\u00fcr Industrie, Pr\u00fcfer und andere Interessengruppen\u201c (fda.gov).<\/div>\n<div><\/div>\n<div><strong>Details zum Webinar:<\/strong><\/div>\n<ul>\n<li>Datum: 20. Juni 2023<\/li>\n<li>Uhrzeit: 15:00 \u2013 16:00 Uhr ET<\/li>\n<\/ul>\n<div>Zu den behandelten Themen geh\u00f6ren die Gestaltung eines DCT, die Durchf\u00fchrung von Fernbesuchen bei klinischen Studien und Aktivit\u00e4ten im Zusammenhang mit klinischen Studien in einem DCT, die Nutzung digitaler Gesundheitstechnologien zur Fernerfassung von Daten in einem DCT, die Rollen und Verantwortlichkeiten des Sponsors und der Pr\u00fcfer in einem DCT usw.<\/div>\n<div><\/div>\n<\/div>\n<ul>\n<li><strong>Lesen Sie mehr dar\u00fcber, wie das RegASK DCT-Handbuch helfen kann:\u00a0<\/strong><strong><a href=\"https:\/\/regask.com\/de\/regulatory-guidebooks-paved-the-way-for-decentralized-clinical-trials\/\" target=\"_blank\" rel=\"noopener\">Regulatorische Leitf\u00e4den ebneten den Weg f\u00fcr dezentrale klinische Studien<\/a><\/strong><\/li>\n<li>M\u00f6chten Sie mehr \u00fcber \u00c4nderungen der DCT-Regelung erfahren? <a href=\"https:\/\/regask.com\/de\/kontakt\/\" target=\"_blank\" rel=\"noopener\">Nehmen Sie Kontakt mit den Experten von RegASK auf.<\/a><\/li>\n<\/ul>\n<div><\/div>\n<a href=\"https:\/\/regask.com\/de\/kontakt\/\" class=\"button secondary\" style=\"border-radius:10px;\">\n\t\t<span>Kontaktieren Sie RegASK f\u00fcr weitere Details<\/span>\n\t<\/a>\n\n<a href=\"https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/decentralized-clinical-trials-dct-draft-guidance-06202023\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>Mehr lesen<\/span>\n\t<\/a>\n\n<div class=\"row\"  id=\"row-498702536\">\n\n\t<div id=\"col-543776716\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<a href=\"https:\/\/regask.com\/de\/fallstudien\/ressourcen-fallstudien-medizinprodukte\/\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>Lesen Sie Fallstudien aus der Medizinger\u00e4tebranche<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>US FDA recently released the draft guidance on decentralized clinical trials and has also scheduled a webinar to discuss this draft guidance. The draft guidance is on &#8211; Decentralized Clinical Trials for Drugs, Biological Products, and Devices Draft Guidance for Industry, Investigators, and Other Stakeholders (fda.gov) Webinar details: Date: June 20, 2023 Time: 3:00 PM&#8230;<\/p>","protected":false},"author":39,"featured_media":3995,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[39],"tags":[40],"class_list":["post-4274","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-devices-insights","tag-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.4 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Webinar: Decentralized Clinical Trials | RegASK<\/title>\n<meta name=\"description\" content=\"US FDA recently released the draft guidance on decentralized clinical trials and has also scheduled a webinar to discuss this draft guidance.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/webinar-der-fda-zu-dezentralisierten-klinischen-studien\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US FDA Announces Webinar to Discuss Decentralized Trial Draft Guidance\" \/>\n<meta property=\"og:description\" content=\"US FDA recently released the draft guidance on decentralized clinical trials and has also scheduled a webinar to discuss this draft guidance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/webinar-der-fda-zu-dezentralisierten-klinischen-studien\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-24T05:42:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-16T16:16:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"US FDA Announces Webinar to Discuss Decentralized Trial&hellip;\",\"datePublished\":\"2023-05-24T05:42:52+00:00\",\"dateModified\":\"2024-10-16T16:16:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/\"},\"wordCount\":213,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"keywords\":[\"Latest Insights\"],\"articleSection\":[\"Medical Devices\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/\",\"name\":\"FDA Webinar: Decentralized Clinical Trials | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"datePublished\":\"2023-05-24T05:42:52+00:00\",\"dateModified\":\"2024-10-16T16:16:15+00:00\",\"description\":\"US FDA recently released the draft guidance on decentralized clinical trials and has also scheduled a webinar to discuss this draft guidance.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-decentralized-clinical-trials-webinar\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png\",\"width\":330,\"height\":300,\"caption\":\"India Proposed Amendment To New Drugs And Clinical Trials Rules\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA-Webinar: Dezentrale klinische Studien | RegASK","description":"Die US-amerikanische FDA hat vor Kurzem den Leitlinienentwurf zu dezentralisierten klinischen Studien ver\u00f6ffentlicht und au\u00dferdem ein Webinar zur Diskussion dieses Leitlinienentwurfs angesetzt.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/webinar-der-fda-zu-dezentralisierten-klinischen-studien\/","og_locale":"de_DE","og_type":"article","og_title":"US FDA Announces Webinar to Discuss Decentralized Trial Draft Guidance","og_description":"US FDA recently released the draft guidance on decentralized clinical trials and has also scheduled a webinar to discuss this draft guidance.","og_url":"https:\/\/regask.com\/de\/webinar-der-fda-zu-dezentralisierten-klinischen-studien\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2023-05-24T05:42:52+00:00","article_modified_time":"2024-10-16T16:16:15+00:00","og_image":[{"width":330,"height":300,"url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/#article","isPartOf":{"@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"US FDA Announces Webinar to Discuss Decentralized Trial&hellip;","datePublished":"2023-05-24T05:42:52+00:00","dateModified":"2024-10-16T16:16:15+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/"},"wordCount":213,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","keywords":["Latest Insights"],"articleSection":["Medical Devices"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/","url":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/","name":"FDA-Webinar: Dezentrale klinische Studien | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","datePublished":"2023-05-24T05:42:52+00:00","dateModified":"2024-10-16T16:16:15+00:00","description":"Die US-amerikanische FDA hat vor Kurzem den Leitlinienentwurf zu dezentralisierten klinischen Studien ver\u00f6ffentlicht und au\u00dferdem ein Webinar zur Diskussion dieses Leitlinienentwurfs angesetzt.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/fda-decentralized-clinical-trials-webinar\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/11\/India-Proposed-Amendment-to-New-Drugs-and-Clinical-Trials-Rules.png","width":330,"height":300,"caption":"India Proposed Amendment To New Drugs And Clinical Trials Rules"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Agentic AI ist eine Plattform f\u00fcr regulatorische Analysen und Workflow-Orchestrierung in den Bereichen Life Sciences und Konsumg\u00fcter. RegASK kombiniert vertikale LLMs, eine Multiagenten-KI-Architektur und eine globale Community von \u00fcber 1.800 Fachexperten, um regulatorische Zukunftsprognosen, Wirkungsanalysen, die Automatisierung von Compliance-Workflows und auditfertige Ergebnisse in \u00fcber 160 L\u00e4ndern bereitzustellen.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Benoit Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/4274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=4274"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/4274\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/3995"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=4274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=4274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=4274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}